InvestorsHub Logo
Followers 1
Posts 269
Boards Moderated 0
Alias Born 05/08/2017

Re: None

Friday, 05/12/2017 4:23:30 PM

Friday, May 12, 2017 4:23:30 PM

Post# of 21544
After reading some of the results of Dr. Alkon with mice (and the related papers), there is no doubt in my mind that if the same/similar effects can be transferred to humans this drug is a blockbuster. The results of PII positively demonstrated that (be p<0.07 as opposed to p<0.05, is not important). These results were obtained when very sick patients were given SOC (i.e. NET improvement when the placebo is not really a placebo for some groups).

Now, if the dosage can be better adjusted with periodic monitoring (to achieve maximum effect) I am sure the results will be substantially better. Not to mention if the drug has cumulative effects (patents improvement with time).

We will know soon. The science is there.

I have been happily adding as the price goes down and own now a substancial chunk of shares. So my disclaimer is that I am very long NTRP.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SNPX News